03133nas a2200385 4500000000100000008004100001260003200042653002600074653004100100653004400141653001400185653003700199100001300236700001500249700001200264700001200276700001800288700001200306700001100318700001200329700001500341700001300356700001300369700001200382700001300394700001500407700001300422700001200435700001200447245019900459300001400658490000700672520204300679022002502722 2026 d c10/2026bScientific Scholar10aAtypical mycobacteria10amycobacteria other than tuberculosis10anon-tuberculous mycobacterial infection10aDiagnosis10aSkin neglected tropical diseases1 aNarang T1 aKathuria S1 aVerma P1 aSingh R1 aVarma-Basil M1 aKumar S1 aRout A1 aRamam M1 aRamesh V R1 aSingal A1 aNarang P1 aSirka C1 aBajpai J1 aBhardwaj A1 aRather S1 aBalai M1 aDogra S00aConsensus guidelines for diagnosis and management of cutaneous non-tuberculous mycobacterial infections by Special Interest Group (SIG) – Skin Neglected Tropical Diseases (NTDs), IADVL Academy a689 - 6980 v923 a

Background

Non tuberculous mycobacterial (NTM) infections are a heterogenous group of infections caused by more than 200 species of mycobacteria other than M. tuberculosis complex and M. leprae . The existing guidelines for treatment of NTM infections focus primarily on pulmonary infection. This consensus statement has been formulated for the diagnosis and management of cutaneous NTM infections (excluding M. marinum and M. ulcerans ).

Objectives

The aim was to develop consensus guidelines for diagnosis and management of cutaneous NTM infections in situations where the organism is identified with known drug susceptibility pattern, and when treatment has to be given empirically.

Methods

The modified DELPHI method was used for developing the guidelines. Agreement by 3 75% experts was considered as consensus. The panel consisted of nine experts including dermatologists, internists and microbiologists. Initially, 50 statements based on Likert scale were drafted and internally and externally validated. Three rounds were conducted, first two were sent by mail and the third was a live discussion on an online platform.

Results

Consensus was met on 33 statements which have been discussed in this article. The statement focusses on four key areas: clinical features, diagnostic criteria, investigations and specific and empirical treatment plans. Clinical diagnostic criteria have been agreed upon. Limitations The statement is based on collective experience of experts rather than real-time data. Hence, it should be interpreted as a guideline.

Conclusion

The consensus statement provides a guideline for dermatologists to identify and diagnose NTM infections. It also provides a step-by-step approach to treating NTM infection when identification of the organism becomes difficult, due to the nature of the disease or due to lack of facilities.

 a0973-3922, 0378-6323